Cellectar Biosciences, Inc. (CLRB) Stock Price, Quote & News - Stock Analysis (2024)

FAQs

Is CLRB a good stock to buy? ›

Cellectar Biosciences has 388.16% upside potential, based on the analysts' average price target. Is CLRB a Buy, Sell or Hold? Cellectar Biosciences has a conensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings. The average price target for Cellectar Biosciences is $15.67.

Cellectar Biosciences Inc quote is equal to 3.080 USD at 2024-04-24. Based on our forecasts, a long-term increase is expected, the "CLRB" stock price prognosis for 2029-04-18 is 72.119 USD. With a 5-year investment, the revenue is expected to be around +2241.52%.

Cellectar BioSciences Stock Prediction 2030

In 2030, the Cellectar BioSciences stock will reach $ 565.45B if it maintains its current 10-year average growth rate. If this Cellectar BioSciences stock prediction for 2030 materializes, CLRB stock will grow 18,240,463,535,972.38% from its current price.

MPWR Stock Forecast FAQ

Monolithic Power has 13.73% upside potential, based on the analysts' average price target. Is MPWR a Buy, Sell or Hold? Monolithic Power has a conensus rating of Strong Buy which is based on 9 buy ratings, 0 hold ratings and 0 sell ratings.

James Caruso

Mr. Caruso was appointed Cellectar Biosciences' President and Chief Executive Officer and a director in June 2015.

Cellectar Biosciences Inc (Cellectar), is a biopharmaceutical company that discovers, develops and commercializes drugs for treatment of cancer. The company's proprietary technology, phospholipid drug conjugates (PDC) delivery platform develops PDCs for the treatment and diagnosis of cancer.

Lumen Stock Price Forecast 2024-2025

Lumen price started in 2024 at $1.48. Today, Lumen traded at $1.19, so the price decreased by -20% from the beginning of the year. The forecasted Lumen price at the end of 2024 is $1.43 - and the year to year change -3%.

Imperial Petroleum Inc. stock forecast for 2025: $ 12.26 (227.88%)

6 analysts offering 12-month price forecasts for Faraday Future Intelligent Electric Inc (FFIE) have a share price target of $10. This median of share price forecast represents a 17918.02% upside from the latest price of $0.06 as on 24.04. 24.

If Nio stock's price follows the S&P 500 index's multi-year growth rate, it could reach as high as $26.82 in 2040 and $77.05 by 2050. If the stock were to follow the more expedited growth rate of the QTEC index, Nio could reach as high as $49.43 by 2040 and $203.49 by 2050.

What is Ginkgo Bioworks stock price prediction for 2030? ›

Stock Prediction 2030. In 2030, the Ginkgo Bioworks Holdings, Inc. stock will reach $ 0.155310 if it maintains its current 10-year average growth rate.

What do analysts say about Castle Biosciences? Castle Biosciences's analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

Edison International's analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.

Helix Energy Solutions Group's analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.

Annovis Bio's analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.